Latest Neuroprotection Stories
Researchers at the Salk Institute have discovered a startling feature of early brain development that helps to explain how complex neuron wiring patterns are programmed using just a handful of critical genes.
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting ™, in Dallas, Texas, researchers will report that early transplantation of human placenta-derived mesenchymal stem cells into the lateral ventricles of neonatal rats with birth-related brain damage is possible, and that the donor cells can survive and migrate in the recipient's brain.
Glaucoma is a major cause of vision loss in the United States, affecting about 2.2 million Americans.
Treatment that increases brain levels of a crucial regulatory enzyme may slow the loss of brain cells that characterize Huntington’s disease (HD) and other neurodegenerative disorders, according to this study.
Erythropoietin or EPO might be considered a "performance enhancing" substance for athletes, but new research published online in The FASEB Journal (http://www.fasebj.org) shows that these enhancements come at a high cost--increased risk of vascular problems in the brain.
Save the neurons! A new study suggests laquinimod triggers immune cells within the central nervous system produce and release brain-derived neurotrophic factor, BDNF, contributing to the repair or survival of neurons; therefore limiting brain damage.
Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS).
Huntington’s disease is a devastating genetic disorder that causes degeneration of nerve cells in the brain.
A commonly used supplement is likely to improve outcomes and recovery for individuals who sustain a spinal cord injury (SCI).
- A woman chauffeur.
- A woman who operates an automobile.